Skip to main content
Erschienen in: Wiener klinische Wochenschrift 17-18/2012

01.09.2012 | original article

A preliminary study about the effects of warm priming solution on oxidative stress and postoperative atrial fibrillation in open heart surgery

verfasst von: Asoc. Prof. Mustafa Buyukates, MD, Asoc. Prof. Serefden Acikgoz, MD, Asoc. Prof. Erol Aktunc, MD, Asoc. Prof. Ozer Kandemir, MD, Asoc. Prof. Sait Mesut Dogan, MD, Prof. Mustafa Aydin, MD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 17-18/2012

Einloggen, um Zugang zu erhalten

Summary

Background

An important reason for production of ischemia and reperfusion injury and oxidative stress is the sudden and rapid changes in body temperature during the institution of cardiopulmonary bypass. The aim of this study was to investigate the effects of warm priming solution on oxidative stress and atrial fibrillation.

Methods

This is a preliminary prospective study on a group of 40 patients who underwent elective coronary artery bypass grafting operation using cardiopulmonary bypass. Patients were randomized into two groups, each consisting of 20 patients; one group was primed with a solution at 20 °C and the other at 36 °C initially for cardiopulmonary bypass. Blood samples from both of the groups were drawn preoperatively and at the 15th and 60th min of aortic cross clamping and 24th h following the surgery. Serum malondialdehyde levels, protein carbonyl content and total antioxidant status were detected. Patients were followed for postoperative atrial fibrillation.

Results

Malondialdehyde and protein carbonyl content were found to be significantly higher and total antioxidant status was concordantly lower in the cold priming group at the 15th and 60th min, recovering to the normal range postoperatively at the 24th h. Patients in the cold priming group had developed a significantly higher rate of atrial fibrillation when compared with the patients in the warm priming group during the postoperative period.

Conclusion

In conclusion, although this study has its limitation about the sample size it may provide an insight about the probable preventive effects of 36 °C warm priming solution in oxidative stress and postoperative atrial fibrillation.
Literatur
1.
Zurück zum Zitat Rodrigo R. Prevention of postoperative atrial fibrillation: novel and safe strategy based on the modulation of the antioxidant system. Front Physiol. 2012;3:93.PubMedCrossRef Rodrigo R. Prevention of postoperative atrial fibrillation: novel and safe strategy based on the modulation of the antioxidant system. Front Physiol. 2012;3:93.PubMedCrossRef
2.
Zurück zum Zitat Venardos KM, Perkins A, Headrick J, Kaye DM. Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review. Curr Med Chem. 2007;14:1539–49.PubMedCrossRef Venardos KM, Perkins A, Headrick J, Kaye DM. Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review. Curr Med Chem. 2007;14:1539–49.PubMedCrossRef
3.
Zurück zum Zitat Gonenc A, Hacisevki A, Bakkaloglu B, Soyagir A, Torun M, Karagoz H, et al. Oxidative stress is decreased in off-pump versus on-pump coronary artery surgery. J Biochem Mol Biol. 2006;39:377–82.PubMedCrossRef Gonenc A, Hacisevki A, Bakkaloglu B, Soyagir A, Torun M, Karagoz H, et al. Oxidative stress is decreased in off-pump versus on-pump coronary artery surgery. J Biochem Mol Biol. 2006;39:377–82.PubMedCrossRef
4.
Zurück zum Zitat Pantke U, Volk T, Schmutzler M, Kox WJ, Sitte N, Grune T. Oxidized proteins as a marker of oxidative stress during coronary heart surgery. Free Radic Biol Med. 1999;27:1080–6.PubMedCrossRef Pantke U, Volk T, Schmutzler M, Kox WJ, Sitte N, Grune T. Oxidized proteins as a marker of oxidative stress during coronary heart surgery. Free Radic Biol Med. 1999;27:1080–6.PubMedCrossRef
5.
Zurück zum Zitat Pinzani P, Petruzzi E, Orlando C, Gallai R, Serio M, Pazzagli M. Serum antioxidant capacity in healthy and diabetic subjects as determined by enhanced chemiluminescence. J Biolumin Chemilumin. 1998;13:321–5.PubMedCrossRef Pinzani P, Petruzzi E, Orlando C, Gallai R, Serio M, Pazzagli M. Serum antioxidant capacity in healthy and diabetic subjects as determined by enhanced chemiluminescence. J Biolumin Chemilumin. 1998;13:321–5.PubMedCrossRef
6.
Zurück zum Zitat Elgebaly SA, Houser SL, el Kerm AF, Doyle K, Gillies C, Dalecki K. Evidence of cardiac inflammation after open heart operations. Ann Thorac Surg. 1994;57:391–6.PubMedCrossRef Elgebaly SA, Houser SL, el Kerm AF, Doyle K, Gillies C, Dalecki K. Evidence of cardiac inflammation after open heart operations. Ann Thorac Surg. 1994;57:391–6.PubMedCrossRef
7.
Zurück zum Zitat Gonenc A, Hacişevki A, Griffiths HR, Torun M, Bakkaloglu B, Simsek B. Free radical reaction products and antioxidant capacity in beating heart coronary artery surgery compared to conventional bypass. Biochemistry (Mosc). 2011;76(6):677–85.CrossRef Gonenc A, Hacişevki A, Griffiths HR, Torun M, Bakkaloglu B, Simsek B. Free radical reaction products and antioxidant capacity in beating heart coronary artery surgery compared to conventional bypass. Biochemistry (Mosc). 2011;76(6):677–85.CrossRef
8.
Zurück zum Zitat Hunter MI, Nlemadim BC, Davidson DL. Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients. Neurochem Res. 1985;10:1645–52.PubMedCrossRef Hunter MI, Nlemadim BC, Davidson DL. Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients. Neurochem Res. 1985;10:1645–52.PubMedCrossRef
9.
Zurück zum Zitat Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990;186:464–78.PubMedCrossRef Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990;186:464–78.PubMedCrossRef
10.
Zurück zum Zitat McPherson RA. Specific proteins. In: Henry JB, editor. Clinical diagnosis and mangement by laboratory methods. 20th ed. Philadelphia: WB Saunders Company; 2001. p. 249–63. McPherson RA. Specific proteins. In: Henry JB, editor. Clinical diagnosis and mangement by laboratory methods. 20th ed. Philadelphia: WB Saunders Company; 2001. p. 249–63.
11.
Zurück zum Zitat Juránek I, Bezek S. Controversy of free radical hypothesis: reactive oxygen species—cause or consequence of tissue injury? Gen Physiol Biophys. 2005;24:263–278.PubMed Juránek I, Bezek S. Controversy of free radical hypothesis: reactive oxygen species—cause or consequence of tissue injury? Gen Physiol Biophys. 2005;24:263–278.PubMed
12.
Zurück zum Zitat Jones WK, Brown M, Ren X, He S, McGuinness M. NF-kappaB as an integrator of diverse signaling pathways: the heart of myocardial signaling? Cardiovasc Toxicol. 2003;3(3):229–54.PubMedCrossRef Jones WK, Brown M, Ren X, He S, McGuinness M. NF-kappaB as an integrator of diverse signaling pathways: the heart of myocardial signaling? Cardiovasc Toxicol. 2003;3(3):229–54.PubMedCrossRef
13.
Zurück zum Zitat Debreceni B, Debreceni L. Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases? Cardiovasc Ther. 2011;00:1–7. doi:10.1111/j.1755-5922.2011.00266.x. Debreceni B, Debreceni L. Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases? Cardiovasc Ther. 2011;00:1–7. doi:10.1111/j.1755-5922.2011.00266.x.
14.
Zurück zum Zitat Kunt AS, Selek S, Celik H, Demir D, Erel O, Andac MH. Decrease of total antioxidant capacity during coronary artey bypass surgery. Mt Sinai J Med. 2006;73:777–83.PubMed Kunt AS, Selek S, Celik H, Demir D, Erel O, Andac MH. Decrease of total antioxidant capacity during coronary artey bypass surgery. Mt Sinai J Med. 2006;73:777–83.PubMed
15.
Zurück zum Zitat Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med. 2001;135:1061–73.PubMed Maisel WH, Rawn JD, Stevenson WG. Atrial fibrillation after cardiac surgery. Ann Intern Med. 2001;135:1061–73.PubMed
16.
Zurück zum Zitat Elahi M, Hadjinikolaou L, Galinanes M. Incidence and clinical consequences of atrial fibrillation within 1 year of first-time isolated coronary bypass surgery. Circulation 2003;108(Suppl II):II-207–12. Elahi M, Hadjinikolaou L, Galinanes M. Incidence and clinical consequences of atrial fibrillation within 1 year of first-time isolated coronary bypass surgery. Circulation 2003;108(Suppl II):II-207–12.
17.
Zurück zum Zitat Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, Barash PG, Hsu PH, Mangano DT. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004;291:1720–9.PubMedCrossRef Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, Barash PG, Hsu PH, Mangano DT. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004;291:1720–9.PubMedCrossRef
18.
Zurück zum Zitat Zimmer J, Pezzullo J, Choucair W, Southard J, Kokkinos P, Karasik P, Greenberg MD, Singh SN. Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery. Am J Cardiol. 2003;91:1137–40.PubMedCrossRef Zimmer J, Pezzullo J, Choucair W, Southard J, Kokkinos P, Karasik P, Greenberg MD, Singh SN. Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery. Am J Cardiol. 2003;91:1137–40.PubMedCrossRef
19.
Zurück zum Zitat Gillespie EL, White CM, Kluger J, Sahni J, Gallagher R, Coleman CI. A hospital perspective on the cost-effectiveness of beta-blockade for prophylaxis of atrial fibrillation after cardiothoracic surgery. Clin Ther. 2005;27:1963–9. Gillespie EL, White CM, Kluger J, Sahni J, Gallagher R, Coleman CI. A hospital perspective on the cost-effectiveness of beta-blockade for prophylaxis of atrial fibrillation after cardiothoracic surgery. Clin Ther. 2005;27:1963–9.
20.
Zurück zum Zitat Gillespie EL, White CM, Kluger J, Rancourt JA, Gallagher R, Coleman CI. Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery. Pharmacotherapy 2006;26:499–504.PubMedCrossRef Gillespie EL, White CM, Kluger J, Rancourt JA, Gallagher R, Coleman CI. Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery. Pharmacotherapy 2006;26:499–504.PubMedCrossRef
21.
Zurück zum Zitat Alqahtani AA. Atrial fibrillation post cardiac surgery trends toward management. Heart Views. 2010;11:57–63.PubMedCrossRef Alqahtani AA. Atrial fibrillation post cardiac surgery trends toward management. Heart Views. 2010;11:57–63.PubMedCrossRef
22.
Zurück zum Zitat Elahi M, Flatman S, Matata BM. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress mediated myocardial injury phenomenon. Eur J Cardiovasc Prev Rehabil. 2008;15:735–741.PubMedCrossRef Elahi M, Flatman S, Matata BM. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress mediated myocardial injury phenomenon. Eur J Cardiovasc Prev Rehabil. 2008;15:735–741.PubMedCrossRef
23.
Zurück zum Zitat Van Wagoner DR. Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target. J Cardiovasc Pharmacol. 2008;52:306–13.PubMedCrossRef Van Wagoner DR. Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target. J Cardiovasc Pharmacol. 2008;52:306–13.PubMedCrossRef
24.
Zurück zum Zitat Neuman RB, Bloom HL, Shukrullah I, Darrow LA, Kleinbaum D, Jones DP, Dudley SC Jr. Oxidative stress markers are associated with persistent atrial fibrillation. Clin Chem. 2007;53:1652–7.PubMedCrossRef Neuman RB, Bloom HL, Shukrullah I, Darrow LA, Kleinbaum D, Jones DP, Dudley SC Jr. Oxidative stress markers are associated with persistent atrial fibrillation. Clin Chem. 2007;53:1652–7.PubMedCrossRef
25.
Zurück zum Zitat Negi S, Sovari AA, Dudley SC Jr. Atrial fibrillation: the emerging role of inflammation and oxidative stress. Cardiovasc Hematol Disord Drug Targets. 2010;10:262–8.PubMed Negi S, Sovari AA, Dudley SC Jr. Atrial fibrillation: the emerging role of inflammation and oxidative stress. Cardiovasc Hematol Disord Drug Targets. 2010;10:262–8.PubMed
26.
Zurück zum Zitat Van Wagoner DR. Molecular basis of atrial fibrillation: a dream or a reality? J Cardiovasc Electrophysiol. 2003;14:667–9.PubMedCrossRef Van Wagoner DR. Molecular basis of atrial fibrillation: a dream or a reality? J Cardiovasc Electrophysiol. 2003;14:667–9.PubMedCrossRef
27.
Zurück zum Zitat Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol. 2007;115:135–43.PubMedCrossRef Korantzopoulos P, Kolettis TM, Galaris D, Goudevenos JA. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol. 2007;115:135–43.PubMedCrossRef
28.
Zurück zum Zitat Killig F, Stark G. Photodynamic activation of ion transport through lipid membranes and its correlation with an increased dielectric constant of the membrane. Biochim Biophys Acta. 2002;1564:207–13.PubMedCrossRef Killig F, Stark G. Photodynamic activation of ion transport through lipid membranes and its correlation with an increased dielectric constant of the membrane. Biochim Biophys Acta. 2002;1564:207–13.PubMedCrossRef
29.
Zurück zum Zitat Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? Eur Heart J. 2006;27:136–149.PubMedCrossRef Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? Eur Heart J. 2006;27:136–149.PubMedCrossRef
30.
Zurück zum Zitat Koniari I, Apostolakis E, Rogkakou C, Baikoussis NG, Dougenis D. Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: a systematic review. J Cardiothorac Surg. 2010;5:121.PubMedCrossRef Koniari I, Apostolakis E, Rogkakou C, Baikoussis NG, Dougenis D. Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: a systematic review. J Cardiothorac Surg. 2010;5:121.PubMedCrossRef
31.
Zurück zum Zitat Davis EM, Packard KA, Hilleman DE. Pharmacologic prophylaxis of postoperative atrial fibrillation in patients undergoing cardiac surgery: beyond beta-blockers. Pharmacotherapy. 2010;30:749.PubMedCrossRef Davis EM, Packard KA, Hilleman DE. Pharmacologic prophylaxis of postoperative atrial fibrillation in patients undergoing cardiac surgery: beyond beta-blockers. Pharmacotherapy. 2010;30:749.PubMedCrossRef
Metadaten
Titel
A preliminary study about the effects of warm priming solution on oxidative stress and postoperative atrial fibrillation in open heart surgery
verfasst von
Asoc. Prof. Mustafa Buyukates, MD
Asoc. Prof. Serefden Acikgoz, MD
Asoc. Prof. Erol Aktunc, MD
Asoc. Prof. Ozer Kandemir, MD
Asoc. Prof. Sait Mesut Dogan, MD
Prof. Mustafa Aydin, MD
Publikationsdatum
01.09.2012
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 17-18/2012
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-012-0222-1

Weitere Artikel der Ausgabe 17-18/2012

Wiener klinische Wochenschrift 17-18/2012 Zur Ausgabe

mitteilungen der gesellschaft der ärzte in Wien

Veranstaltungen